This study has four objectives: 1) to provide investigators the opportunity to study bone specimens from patients with various skeletal diseases; 2) to treat patients with skeletal diseases at the NIH; 3) to expose NIH trainees to certain skeletal diseases; and 4) to gain more knowledge about skeletal diseases and stimulate further study of bone biology.

Official Title

Conditions

– Bone Disease

Study Type

Interventional

Study Design

Training

Further Details

Human diseases are commonly manifested in the skeletal system. The skeleton may be the primary or secondary target of the disease and the disease may be congenital or acquired. While understanding of the molecular and cellular biology of the bone has blossomed in the last several years, much remains to be understood about the underlying biology of the skeleton. The gaps in the understanding of skeletal biology are evident in the paucity of tissue-specific therapies for skeletal diseases. The objectives of this protocol are fourfold: 1) to allow us to receive bone specimens from investigators outside the NIH, 2) to provide a protocol within which patients with skeletal disease can be evaluated and treated here at NIH, 3) to provide a protocol under which trainees can evaluate patients with skeletal diseases and 4) to provide a pool of patients with skeletal diseases from which questions of basic pathogenetic mechanisms may serve as the basis for future studies. Within this study, bone formation will be assessed using cell and molecular biological approaches when specimens are sent from outside of NIH, and when recruited to NIH, patients will undergo clinically-indicated testing and possibly receive treatment which will be limited to approved medications.

Study Start

Eligibility & Criteria

Genders Eligible for Study: Both Criteria INCLUSION CRITERIA:Specimens to be shipped will be considered either “surgical waste” or the harvesting of the specimen will be approved by an IRB-approved protocol at the sending institution. The specimen will be sent with a copy of the signed consent.Patients of any age, gender, or ethnicity with skeletal diseases who are not enrolled in other protocols which otherwise allow for the evaluation and treatment of these diseases.Women of childbearing age or lactating will have pregnancy ruled-out with a serum pregnancy test and/or not undergo testing involving radiation or receive medications without demonstrated safety in pregnancy.Patients must be referred from a practitioner who will continue their care/evaluation upon discharge, or in tandem with this protocol.EXCLUSION CRITERIA:Patients with significant cognitive impairment who are unable to give informed consent. Patients with achondroplasias are often mentally compromised.Patients with serious, uncontrolled metabolic organ system dysfunction (decompensated heart failure, diabetes, etc.).

Total Enrolment

999999

Contact Details

[1] National Institute of Dental and Craniofacial Research (NIDCR)

All content and media on the HealthEngine Blog is created and published online for informational purposes only. It is not intended to be a substitute for professional medical advice and should not be relied on as health or personal advice. Always seek the guidance of your doctor or other qualified health professional with any questions you may have regarding your health or a medical condition. Never disregard the advice of a medical professional, or delay in seeking it because of something you have read on this Website. If you think you may have a medical emergency, call your doctor, go to the nearest hospital emergency department, or call the emergency services immediately.